SABCS 2022 | Challenges HPCs face when monitoring for cardiotoxicity in patients with breast cancer

Ilana Schlam, MD, Tufts Medical Center, Boston, MA, discusses the challenges healthcare practitioners face when monitoring for cardiotoxicity in breast cancer patients, including the lack of standardization in monitoring cardiotoxicity. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.